亿胜生物科技：多剂量玻璃酸钠滴眼液(0.3%)于中国商业化获批准

Core Viewpoint - The company Yi Sheng Bio-Tech (01061) announced that its indirect subsidiary, Guangdong Hanfeng Baisheng Pharmaceutical Co., Ltd., has received approval from the National Medical Products Administration to register and commercialize a multi-dose sodium hyaluronate eye drop solution (0.3%) in the People's Republic of China [1] Group 1 - The approved product is a multi-dose eye drop solution containing 0.3% sodium hyaluronate (5ml: 15mg) [1] - The eye drop solution is indicated for the treatment and relief of various endogenous eye diseases such as dry eye syndrome, Stevens-Johnson syndrome, and exogenous eye diseases, as well as damage caused by surgery, medication, trauma, or wearing contact lenses [1]